Literature DB >> 10070891

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.

S F Zerp1, A van Elsas, L T Peltenburg, P I Schrier.   

Abstract

In melanoma, the relationship between sun exposure and the origin of mutations in either the N-ras oncogene or the p53 tumour-suppressor gene is not as clear as in other types of skin cancer. We have previously shown that mutations in the N-ras gene occur more frequently in melanomas originating from sun-exposed body sites, indicating that these mutations are UV induced. To investigate whether sun exposure also affects p53 in melanoma, we analysed 81 melanoma specimens for mutations in the p53 gene. The mutation frequency is higher than thus far reported: 17 specimens (21%) harbour one or more p53 mutations. Strikingly, 17 out of 22 mutations in p53 are of the C:G to TA or CC:GG to TT:AA transitional type, strongly suggesting an aetiology involving UV exposure. Interestingly, the p53 mutation frequency in metastases was much lower than in primary tumours. In the case of metastases, a role for sun exposure was indicated by the finding that the mutations are present exclusively in skin metastases and not in internal metastases. Together with a relatively frequent occurrence of silent third-base pair mutations in primary melanomas, this indicates that the p53 mutations, at least in these tumours, have not contributed to melanomagenesis and may have originated after establishment of the primary tumour.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070891      PMCID: PMC2362648          DOI: 10.1038/sj.bjc.6690147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.

Authors:  Y Murakami; K Hayashi; T Sekiya
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

2.  p53 mutations in basal cell carcinomas.

Authors:  P Rady; F Scinicariello; R F Wagner; S K Tyring
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

3.  p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin.

Authors:  C Campbell; A G Quinn; Y S Ro; B Angus; J L Rees
Journal:  J Invest Dermatol       Date:  1993-06       Impact factor: 8.551

4.  Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.

Authors:  J S Castresana; M P Rubio; J J Vázquez; M Idoate; A J Sober; B R Seizinger; R L Barnhill
Journal:  Int J Cancer       Date:  1993-10-21       Impact factor: 7.396

5.  Mutational analysis of the human p53 gene in malignant melanoma.

Authors:  M Volkenandt; U Schlegel; D M Nanus; A P Albino
Journal:  Pigment Cell Res       Date:  1991-02

6.  p53 gene mutations in human epithelial skin cancers.

Authors:  J P Molès; C Moyret; B Guillot; P Jeanteur; J J Guilhou; C Theillet; N Basset-Sèguin
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

7.  High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity.

Authors:  S Kanjilal; W E Pierceall; K K Cummings; M L Kripke; H N Ananthaswamy
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

8.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.

Authors:  S Kress; C Sutter; P T Strickland; H Mukhtar; J Schweizer; M Schwarz
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

10.  Mutation and expression of the p53 gene in malignant melanoma cell lines.

Authors:  J Weiss; K Schwechheimer; W K Cavenee; M Herlyn; K C Arden
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

View more
  24 in total

1.  Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Authors:  José Luis Soto Martínez; Carmen M Cabrera Morales; Sabio Serrano Ortega; Miguel Angel López-Nevot
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

2.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 3.  Melanoma genetics and the development of rational therapeutics.

Authors:  Yakov Chudnovsky; Paul A Khavari; Amy E Adams
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 4.  cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.

Authors:  Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-05       Impact factor: 3.507

5.  A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells.

Authors:  Madeleine Gold; Yusufi Mujahid; Khursheed Ahmed; Hana Kostrhunova; Jana Kasparkova; Viktor Brabec; Bernhard Biersack; Rainer Schobert
Journal:  J Biol Inorg Chem       Date:  2019-06-19       Impact factor: 3.358

6.  Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.

Authors:  Dae Won Kim; Lauren E Haydu; Aron Y Joon; Roland L Bassett; Alan E Siroy; Michael T Tetzlaff; Mark J Routbort; Rodabe N Amaria; Jennifer A Wargo; Jennifer L McQuade; Jan Kemnade; Patrick Hwu; Scott E Woodman; Jason Roszik; Kevin B Kim; Jeffrey E Gershenwald; Alexander J Lazar; Michael A Davies
Journal:  Cancer       Date:  2016-12-02       Impact factor: 6.860

7.  Classifying melanocytic tumors based on DNA copy number changes.

Authors:  Boris C Bastian; Adam B Olshen; Philip E LeBoit; Daniel Pinkel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma.

Authors:  Brozyna Anna; Zbytek Blazej; Granese Jacqueline; Carlson J Andrew; Ross Jeffrey; Slominski Andrzej
Journal:  Expert Rev Dermatol       Date:  2007

9.  Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.

Authors:  Osnat Ashur-Fabian; Aaron Avivi; Luba Trakhtenbrot; Konstantin Adamsky; Meytal Cohen; Gadi Kajakaro; Alma Joel; Ninette Amariglio; Eviatar Nevo; Gideon Rechavi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

10.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.